Journal articles on the topic 'BRCA1'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'BRCA1.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Friedlander, Michael, Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Alla Sergeevna Lisyanskaya, et al. "Efficacy of maintenance olaparib for newly diagnosed, advanced ovarian cancer patients (pts) by BRCA1 or BRCA2 mutation in the phase III SOLO1 trial." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 5551. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.5551.
Full textZhang, Yinuo. "BRCA1, BRCA2 and primary ovarian insufficiency." E3S Web of Conferences 165 (2020): 05009. http://dx.doi.org/10.1051/e3sconf/202016505009.
Full textShao, Changxia, Michael S. Chang, Fred C. Lam, Andrew R. Marley, Huilin Tang, Yiqing Song, Chelsey Miller, et al. "A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer." Journal of Oncology 2022 (July 20, 2022): 1–12. http://dx.doi.org/10.1155/2022/5830475.
Full textRichters, Lisa Katharina, Philip C. Schouten, Stefan Kommoss, Jan Hauke, Alexander Burges, Dimo Dietrich, Ahmed El-Balat, et al. "BRCA-like classification in ovarian cancer: Results from the AGO-TR1-trial." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 5546. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.5546.
Full textWang, Aifen, Robert W. Holloway, Lijuan Cui, Yan Sun, and Zihan Zhao. "Association betweenBRCA1 and BRCA2 mutations and prognosis in women with endometrial carcinoma." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e17115-e17115. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e17115.
Full textLabidi-Galy, Sana Intidhar, Manuel Rodrigues, Jose L. Sandoval, Jean Emmanuel Kurtz, Florian Heitz, Anna Maria Mosconi, Ignacio Romero, et al. "Efficacy of maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced ovarian cancer according to BRCA mutation genotype in the phase III PAOLA-1/ENGOT-ov25 trial." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 5571. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.5571.
Full textLabidi-Galy, Sana Intidhar, Manuel Rodrigues, Jose L. Sandoval, Jean Emmanuel Kurtz, Florian Heitz, Anna Maria Mosconi, Ignacio Romero, et al. "Efficacy of maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced ovarian cancer according to BRCA mutation genotype in the phase III PAOLA-1/ENGOT-ov25 trial." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 5571. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.5571.
Full textPonce, Jordi, Sergi Fernandez-Gonzalez, Iris Calvo, Maite Climent, Judith Peñafiel, Lidia Feliubadaló, Alex Teulé, et al. "Assessment of ovarian reserve and reproductive outcomes in BRCA1 or BRCA2 mutation carriers." International Journal of Gynecologic Cancer 30, no. 1 (November 27, 2019): 83–88. http://dx.doi.org/10.1136/ijgc-2019-000626.
Full textSy, Shirley M. H., Michael S. Y. Huen, and Junjie Chen. "PALB2 is an integral component of the BRCA complex required for homologous recombination repair." Proceedings of the National Academy of Sciences 106, no. 17 (April 15, 2009): 7155–60. http://dx.doi.org/10.1073/pnas.0811159106.
Full textArun, Banu, Angelica Gutierrez Barrera, Rachel M. Layman, Stephen K. Gruschkus, Isabelle Bedrosian, Constance T. Albarracin, Carlos Hernando Barcenas, Vicente Valero, Jennifer Keating Litton, and Debu Tripathy. "Outcome of patients with breast cancer and a germline BRCA mutation in a prospective cohort." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 1544. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1544.
Full textFoglietta, Jennifer, Vienna Ludovini, Fortunato Bianconi, Lorenza Pistola, Maria Sole Reda, Antonella Al-Refaie, Francesca Romana Tofanetti, et al. "Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study." Genes 11, no. 8 (August 12, 2020): 925. http://dx.doi.org/10.3390/genes11080925.
Full textShao, Changxia, Andrew Marley, Huilin Tang, Jun Wan, Chelsey Miller, Madeline Brown, Yiqing Song, Jiali Han, and Gboyega Adeboyeje. "A comprehensive literature review and meta-analysis on prognostic value of BRCAm, HRRm and HRD+ across tumor types." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 3125. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3125.
Full textRhiem, K., C. Fischer, K. Bosse, B. Wappenschmidt, and R. K. Schmutzler. "Increased risk of cervical cancer in high-risk families with and without mutations in the BRCA1 and BRCA2 genes." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 5588. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.5588.
Full textKauff, Noah D., Susan M. Domchek, Tara M. Friebel, Mark E. Robson, Johanna Lee, Judy E. Garber, Claudine Isaacs, et al. "Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study." Journal of Clinical Oncology 26, no. 8 (March 10, 2008): 1331–37. http://dx.doi.org/10.1200/jco.2007.13.9626.
Full textBrankovic-Magic, Mirjana, Jelena Dobricic, Radmila Jankovic, Irene Konstantopoulou, Drakoulis Yannoukakos, and Sinisa Radulovic. "Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?" Archive of Oncology 14, no. 3-4 (2006): 131–35. http://dx.doi.org/10.2298/aoo0604131b.
Full textTun, N. M., G. M. Villani, and K. Ong. "Risk of having BRCA mutations in women with triple-negative breast cancer: A systematic review and meta-analysis." Journal of Clinical Oncology 29, no. 27_suppl (September 20, 2011): 160. http://dx.doi.org/10.1200/jco.2011.29.27_suppl.160.
Full textMurciano-Goroff, Yonina R., Alison M. Schram, Ezra Rosen, Yelena Y. Janjigian, Michael F. Berger, Mark Donoghue, Chaitanya Bandlamudi, and Alexander E. Drilon. "BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 3012. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3012.
Full textReisinger, Raquel, Sergiusz Wesolowski, Umang Swami, Pedro C. Barata, Edgar Javier Hernandez, Roberto Nussenzveig, Gordon Lemmon, et al. "Differences in the genomic landscape of advanced prostate cancer (aPC) patients (pts) with BRCA1 versus BRCA2 mutations as detected by machine learning analysis of the comprehensive genomic profile (CGP) of cell-free DNA (cfDNA)." Journal of Clinical Oncology 39, no. 6_suppl (February 20, 2021): 162. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.162.
Full textBracci, Ciarapica, Zabaleta, Tartaglione, Pirozzi, Giuliani, Piva, et al. "BRCA1 and BRCA2 Gene Expression: Diurnal Variability and Influence of Shift Work." Cancers 11, no. 8 (August 9, 2019): 1146. http://dx.doi.org/10.3390/cancers11081146.
Full textChahla, Elie, Antonio Cheesman, Suzanne M. Mahon, Robert W. Garrett, Ben P. Bradenham, Theresa L. Schwartz, Louay Omran, Jason R. Taylor, and Samer Alkaade. "Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations." Scientifica 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/5619358.
Full textAtchley, Deann P., Constance T. Albarracin, Adriana Lopez, Vicente Valero, Christopher I. Amos, Ana Maria Gonzalez-Angulo, Gabriel N. Hortobagyi, and Banu K. Arun. "Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer." Journal of Clinical Oncology 26, no. 26 (September 10, 2008): 4282–88. http://dx.doi.org/10.1200/jco.2008.16.6231.
Full textKiechle, M. "Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3." Senologie - Zeitschrift für Mammadiagnostik und -therapie 8, no. 02 (June 2011): 103. http://dx.doi.org/10.1055/s-0031-1271518.
Full textSokol, Ethan, Smruthy Sivakumar, Brennan Decker, Jeffrey Ross, and Priti Hegde. "Abstract P5-13-02: Serially biopsied BRCA1/2 mutant breast tumors frequently acquire alterations in BRCA1, BRCA2, and CREBBP." Cancer Research 82, no. 4_Supplement (February 15, 2022): P5–13–02—P5–13–02. http://dx.doi.org/10.1158/1538-7445.sabcs21-p5-13-02.
Full textBisgin, Atil, Ibrahim Boga, Ozge Sonmezler, Cem Mujde, Abdullah Hanta, and Sevcan Tug Bozdogan. "Meta-analysis and single-center experience on the comprehensive genomic characterization and landscape of BRCA1 and BRCA2 in Turkey." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13611-e13611. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13611.
Full textSahnane, Nora, Ileana Carnevali, Giorgio Formenti, Jvan Casarin, Sofia Facchi, Raffaella Bombelli, Eleonora Di Lauro, et al. "BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor." International Journal of Molecular Sciences 21, no. 24 (December 19, 2020): 9708. http://dx.doi.org/10.3390/ijms21249708.
Full textЖурман, В. Н., Н. Г. Плехова, and М. Л. Филипенко. "Mutational Status of BRCA Genes in Ovarian Cancer." Евразийский онкологический журнал, no. 2 (August 16, 2022): 118–25. http://dx.doi.org/10.34883/pi.2022.10.2.016.
Full textZajchowski, Deborah A., Hugh Salamon, and Ken D. Yamaguchi. "Proliferation pathway aberration frequencies in BRCA1- and BRCA2-mutated ovarian cancers." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 5074. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.5074.
Full textVidra, Radu, Tudor Eliade Ciuleanu, Adina Nemeș, Oana Pascu, Ana Maria Heroiu, Nicoleta Antone, Andreea Iulia Vidrean, et al. "Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients." International Journal of Environmental Research and Public Health 19, no. 7 (April 4, 2022): 4314. http://dx.doi.org/10.3390/ijerph19074314.
Full textKeung, Yi-Kong, Adriana Hu, Annie Yeung, Amy Chan, and Eddie Hu. "Higher prevalence of BRCA2 mutations among Chinese breast cancer patients in a community oncology clinic." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e12017-e12017. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e12017.
Full textMitamura, Takashi, Masayuki Sekine, Masami Arai, Yuka Shibata, Momoko Kato, Shiro Yokoyama, Hiroko Yamashita, et al. "Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome." Japanese Journal of Clinical Oncology 50, no. 12 (July 17, 2020): 1380–85. http://dx.doi.org/10.1093/jjco/hyaa124.
Full textWen, Lu, Xiuxiu Li, Junping Shi, Shuo Zhang, Rui Wang, Ming Yao, and Jun Guo. "Allele-specific expression mediates primary resistance to poly (ADP-ribose) polymerase inhibitor therapy in a case of BRCA1/2 double-germline mutant gastric cancer." Journal of International Medical Research 48, no. 3 (November 27, 2019): 030006051988622. http://dx.doi.org/10.1177/0300060519886226.
Full textFaermann, Renata, Eitan Friedman, Orit Kaidar-Person, Jonathan Weidenfeld, Malka Brodsky, Anat Shalmon, Osnat Halshtok Neiman, et al. "Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers." Breast Journal 2022 (October 27, 2022): 1–7. http://dx.doi.org/10.1155/2022/4317693.
Full textLattimore, Vanessa, John Pearson, Arthur Morley-Bunker, kConFab Investigators, Amanda Spurdle, Bridget Robinson, Margaret Currie, and Logan Walker. "Quantifying BRCA1 and BRCA2 mRNA Isoform Expression Levels in Single Cells." International Journal of Molecular Sciences 20, no. 3 (February 6, 2019): 693. http://dx.doi.org/10.3390/ijms20030693.
Full textAyoub, Jean-Pierre, Hans Wildiers, Michael Friedlander, Banu K. Arun, Hyo S. Han, Shannon Puhalla, Yaroslav Shparyk, et al. "Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial." Therapeutic Advances in Medical Oncology 13 (January 2021): 175883592110596. http://dx.doi.org/10.1177/17588359211059601.
Full textJung, J., E. Kang, J. M. Gwak, A. N. Seo, S. Y. Park, A. S. Lee, H. Baek, S. Chae, E. K. Kim, and S. W. Kim. "Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients." Current Oncology 23, no. 5 (October 26, 2016): 298. http://dx.doi.org/10.3747/co.23.3054.
Full textLi, Jiaheng, Bojin Zhao, Teng Huang, Zixin Qin, and San Ming Wang. "Human BRCA pathogenic variants were originated during recent human history." Life Science Alliance 5, no. 5 (February 14, 2022): e202101263. http://dx.doi.org/10.26508/lsa.202101263.
Full textWeitzel, Jeffrey N., Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, et al. "Prevalence and Type ofBRCAMutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network." Journal of Clinical Oncology 31, no. 2 (January 10, 2013): 210–16. http://dx.doi.org/10.1200/jco.2011.41.0027.
Full textPal, Tuya, Deborah Cragun, Xuefeng Wang, Sean J. Yoder, Tania MESA, Marilin Rosa, Ann Tezak, Anne Weidner, Susan Thomas Vadaparampil, and Catherine Phelan. "Characterization of germline and tumor genomic profile in unselected young black breast cancer patients." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e13090-e13090. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e13090.
Full textNovikova, EI, EA Kudinova, VK Bozhenko, and VA Solodkiy. "Characteristics of BRCA-associated breast cancer in the population of the Russian Federation." Features of HIV and SARS-CoV-2 coinfection in a pandemic, no. 2021(1) (February 2021): 24–29. http://dx.doi.org/10.24075/brsmu.2021.006.
Full textGasparri, Maria Luisa, Serena Bellaminutti, Ammad Ahmad Farooqi, Ilaria Cuccu, Violante Di Donato, and Andrea Papadia. "Endometrial Cancer and BRCA Mutations: A Systematic Review." Journal of Clinical Medicine 11, no. 11 (May 31, 2022): 3114. http://dx.doi.org/10.3390/jcm11113114.
Full textShatavi, Seerin Viviane, Lindsay Dohany, Mohammad Muhsin Chisti, Ishmael A. Jaiyesimi, and Dana Zakalik. "Unique genetic characteristics of BRCA mutation carriers in a cohort of Arab American women." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 1541. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1541.
Full textCaleca, Laura, Mara Colombo, Thomas van Overeem Hansen, Conxi Lázaro, Siranoush Manoukian, Michael T. Parsons, Amanda B. Spurdle, and Paolo Radice. "GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes." Cancers 11, no. 2 (January 28, 2019): 151. http://dx.doi.org/10.3390/cancers11020151.
Full textChoi, Doo Ho, Min Hyuk Lee, Allen E. Bale, Darryl Carter, and Bruce G. Haffty. "Incidence of BRCA1 and BRCA2 Mutations in Young Korean Breast Cancer Patients." Journal of Clinical Oncology 22, no. 9 (May 1, 2004): 1638–45. http://dx.doi.org/10.1200/jco.2004.04.179.
Full textFerrone, Cristina R., Douglas A. Levine, Laura H. Tang, Peter J. Allen, William Jarnagin, Murray F. Brennan, Kenneth Offit, and Mark E. Robson. "BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma." Journal of Clinical Oncology 27, no. 3 (January 20, 2009): 433–38. http://dx.doi.org/10.1200/jco.2008.18.5546.
Full textCastro, Elena, David Olmos, Chee Leng Goh, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Elizabeth Bancroft, et al. "Effect of germ-line BRCA mutations in biochemical relapse and survival after treatment for localized prostate cancer." Journal of Clinical Oncology 31, no. 6_suppl (February 20, 2013): 29. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.29.
Full textArun, Banu, Soley Bayraktar, Diane D. Liu, Angelica M. Gutierrez Barrera, Deann Atchley, Lajos Pusztai, Jennifer Keating Litton, et al. "Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience." Journal of Clinical Oncology 29, no. 28 (October 1, 2011): 3739–46. http://dx.doi.org/10.1200/jco.2011.35.2682.
Full textKwong, A., L. Wong, C. Wong, F. Law, E. Tang, W. Chan, E. S. Ma, J. M. Ford, and D. W. West. "Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e22226-e22226. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e22226.
Full textGraeser, Monika K., Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G. Froster, et al. "Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers." Journal of Clinical Oncology 27, no. 35 (December 10, 2009): 5887–92. http://dx.doi.org/10.1200/jco.2008.19.9430.
Full textJoó, József Gábor, Szabolcs Ládi, B. Zsolt Nagy, and Zoltán Langmár. "Management of hereditary ovarian cancer." Orvosi Hetilap 152, no. 40 (October 2011): 1596–608. http://dx.doi.org/10.1556/oh.2011.29218.
Full textSafra, Tamar, Wei-Chu V. Lai, Tara Berman, Lucia Borgato, Elsa Reich, Maria Alvear, Franco Muggia, and Sharon Pelles-Avraham. "BRCA mutations and outcome in epithelial ovarian cancer (EOC): Experience in ethnically diverse groups." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 5078. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.5078.
Full text